Mesoridazine -- a pharmacodynamic and pharmacokinetic profile.
Available data on the clinical effectiveness and side effects of mesoridazine are reviewed, and an attempt is made to relate clinical efficacy to phenothiazine pharmacokinetics. Both controlled and open-label clinical studies have attested to the efficacy of mesoridazine in schizophrenia, as well as certain other psychiatric disorders. Clinical observations of the effectiveness of mesoridazine in patients refractory to treatment with thioridazine and other neuroleptics may be related to its slow rate of inactivation and to the relatively large proportion of free mesoridazine that is available for penetration to the target sites in the brain.
D001682:Biological Availability; D001921:Brain / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008653:Mesoridazine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D011485:Protein Binding; D011618:Psychotic Disorders / Q000188:drug therapy; D012725:Sexual Behavior / Q000187:drug effects
D008653:Mesoridazine